Wanbury - Quaterly Results

22 Jun 2022 Evaluate
A fair growth of 11.58% in the revenue at Rs. 1343.94 millions was reported in the March 2022 quarter as compared to Rs. 1204.47 millions during year-ago period.The Total Profit for the quarter ended March 2022 of Rs. 825.45 millions grew from Rs.-89.55 millions Operating profit Margin for the quarter ended March 2022 improved to 134.54% as compared to -5.55% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1343.94 1204.47 11.58 5111.86 3925.18 30.23 5111.86 3925.18 30.23
Other Income 6.41 12.12 -47.11 15.08 24.04 -37.27 15.08 24.04 -37.27
PBIDT 134.54 -5.55 -2524.14 368.21 204.24 80.28 368.21 204.24 80.28
Interest 47.89 57.88 -17.26 206.11 230.75 -10.68 206.11 230.75 -10.68
PBDT 850.33 -63.43 -1440.58 925.78 -26.51 -3592.19 925.78 -26.51 -3592.19
Depreciation 30.02 25.87 16.04 114.50 97.54 17.39 114.50 97.54 17.39
PBT 820.31 -89.30 -1018.60 811.28 -124.05 -753.99 811.28 -124.05 -753.99
TAX -5.14 0.25 -2156.00 -3.46 2.00 -273.00 -3.46 2.00 -273.00
Deferred Tax -5.14 -22.43 -77.08 -3.46 -20.68 -83.27 -3.46 -20.68 -83.27
PAT 825.45 -89.55 -1021.78 814.74 -126.05 -746.36 814.74 -126.05 -746.36
Equity 326.66 250.15 30.59 326.66 250.15 30.59 326.66 250.15 30.59
PBIDTM(%) 10.01 -0.46 -2272.50 7.20 5.20 38.43 7.20 5.20 38.43

Wanbury Share Price

222.50 3.75 (1.71%)
25-Nov-2024 14:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.95
Dr. Reddys Lab 1208.85
Cipla 1497.10
Lupin 2104.90
Zydus Lifesciences 958.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.